We're all set for a new experience. To visit the old Ventura website, click here.
Ventura Wealth Clients Login here

NSEBSE
NSEBSE
noteThere is a 15-minute delay in the prices. To check out the live prices, log in to your Ventura account or open one today.
1D
1W
1M
1Y
3Y
5Y
Max
Open-
High-
Low-
Prev. Close-
Avg. Traded Price-
Volume-

MARKET DEPTH

info2
Total bid0.00
Total ask0.00
OrdersQtyBid
AskQtyOrders

HIGH/LOW

info2
1d
1w
1m
3m
52w

LOW/HIGH

-
-
arrow

LOWER/UPPER CIRCUITS

-
-
arrow
Epigral Limited Stock performance
arrow

KEY OBSERVATIONS

info
positive
negative
neutral
noteAnnual Revenue,rose 32.52%, in the last year to ₹2,565.34 Cr. Its sector's average revenue growth for the last fiscal year was 7.6%.
noteAnnual Net Profit,rose 82.62% in the last year to ₹357.69 Cr. Its sector's average net profit growth for the last fiscal year was 33.44%.
notePrice to Earning Ratio,is 21.91, lower than its sector PE ratio of 54.3.
View more

LONG-TERM PRICE ANALYSIS

info
Stock return5Y CAGR : %
Net profit growth 5Y CAGR : %
Epigral Limited (Formerly known as Meghmani Finechem Limited) is primarily engaged in manufacturing and selling of Chlor Alkali its Derivatives. The company is also engaged in trading of Agrochemical Products. It is an ISO 9001 and ISO 14001-certified company founded in 2007 and recognised as one of the leading producers of chlor alkali and its Derivatives with backward and forward integration facilities.
personal

Grow your wealth with more research recommendations

+91